Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) insider Dawn Christine Maroney sold 20,000 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $8.70, for a total transaction of $174,000.00. Following the transaction, the insider now owns 1,796,097 shares in the company, valued at approximately $15,626,043.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Dawn Christine Maroney also recently made the following trade(s):
- On Friday, July 19th, Dawn Christine Maroney sold 36,700 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.01, for a total transaction of $367,367.00.
- On Wednesday, July 17th, Dawn Christine Maroney sold 23,163 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.00, for a total transaction of $231,630.00.
- On Wednesday, June 12th, Dawn Christine Maroney sold 20,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $8.21, for a total value of $164,200.00.
Alignment Healthcare Trading Up 1.3 %
NASDAQ ALHC opened at $8.70 on Monday. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $10.16. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.57 and a current ratio of 1.57. The company has a market capitalization of $1.66 billion, a price-to-earnings ratio of -10.36 and a beta of 1.43. The company’s 50-day simple moving average is $8.47 and its two-hundred day simple moving average is $6.86.
Institutional Investors Weigh In On Alignment Healthcare
A number of hedge funds have recently made changes to their positions in the stock. Mackenzie Financial Corp grew its stake in Alignment Healthcare by 110.0% in the second quarter. Mackenzie Financial Corp now owns 36,526 shares of the company’s stock valued at $286,000 after purchasing an additional 19,129 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Alignment Healthcare by 20.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock valued at $434,000 after buying an additional 9,595 shares in the last quarter. Deerfield Management Company L.P. Series C grew its position in shares of Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after buying an additional 2,630,788 shares during the last quarter. AQR Capital Management LLC bought a new position in shares of Alignment Healthcare during the 2nd quarter worth approximately $1,512,000. Finally, Hood River Capital Management LLC lifted its position in Alignment Healthcare by 6.4% during the second quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company’s stock valued at $24,294,000 after acquiring an additional 185,854 shares during the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
ALHC has been the subject of a number of research analyst reports. Barclays raised their price target on Alignment Healthcare from $4.50 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, August 5th. TD Cowen lifted their target price on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research report on Tuesday, August 6th. Stifel Nicolaus upped their price target on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a report on Friday, July 26th. Stephens lifted their price objective on shares of Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a report on Friday, May 3rd. Finally, Piper Sandler reissued an “overweight” rating and issued a $10.00 price objective (up from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $10.05.
Get Our Latest Stock Report on Alignment Healthcare
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Further Reading
- Five stocks we like better than Alignment Healthcare
- Investing in Construction Stocks
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Technology Stocks Explained: Here’s What to Know About Tech
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.